Pelthos Therapeutics and Castle Creek Biosciences have agreed to merge, creating a biotechnology company focused on serious skin diseases. The combined company will leverage Castle Creek's gene and cell therapy platform, including the late-stage candidate D-Fi for dystrophic epidermolysis bullosa (DEB), alongside Pelthos' existing dermatology products. This merger aims to diversify the pipeline and accelerate the commercial launch of innovative therapies. The deal is expected to close by Q1 2027, with Pelthos continuing as the combined company's name and ticker on NYSE American.
Pelthos Therapeutics' merger with Castle Creek Biosciences provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 30, 2026 18:43 WIB: Among 150 priced US health-sector stocks, 71 rose and 72 fell. Regeneron Pharmaceuticals Inc (REGN) was up 8.13% at USD 885.30 with a typical hold time of 108 days. Twist Bioscience Corp (TWST) declined 6.61% to USD 161.99, with Pluang order activity showing 36% sell and 64% buy, and a typical hold time of 27 days. BrightSpring Health Services Inc. (BTSG) gained 6.38% to USD 64.06, with 10% sell and 90% buy order activity, and a typical hold time of 10 days.
FirstCash Holdings reported a 28% year-over-year decline in operating income for its American First Finance segment and a 15% drop in lease and loan originations for Q3 2026. This led to a 14.75% stock price decline on October 22, 2026. The Law Offic...
Oxford Square Capital Corp. announced its financial results for Q3 2026, reporting a net asset value (NAV) per share of $1.21, down from $1.29 in Q2. The company declared monthly dividends of $0.015 per share for January, February, and March 2027. Ne...
MADD Canada warns Canadians to avoid impaired driving during Halloween, emphasizing the risks of alcohol, cannabis, and drug-related crashes that cause deaths and injuries annually. The organization urges people to plan safe rides, watch for children...
As Halloween approaches, MADD Canada warns against impaired driving caused by alcohol, cannabis, or drugs, which leads to hundreds of deaths and thousands of injuries annually in Canada. The organization urges people to plan safe transportation if co...
Investec Bank Plc, acting as joint broker for SThree Plc, disclosed share transactions on October 29, 2026. The bank purchased and sold 49,799 ordinary shares of SThree Plc at prices ranging between 297.5 and 306.5 per share. No derivative or option ...
